EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Prognostic Factors in Intestinal-Type Sinonasal Adenocarcinoma: A 10-year Single-Center Retrospective Cohort Study

Sara Pinto Costa Afonso, Ana Carolina Santos Silva, Laurentino Manuel Mendes Leal, Pedro Alberto Pinto da Silva

Journal of Neurological Surgery Part B: Skull Base · 2026-12 · 87 (06) · 695-704

DOI: 10.1055/a-2765-5462 ↗
AbstractBibliografische Angaben

Abstract

Abstract This study assesses the prognostic impact of tumor invasion patterns and anatomical topography in patients with primary intestinal-type sinonasal adenocarcinoma (ITAC). Specifically, we evaluate the relationship between key invasion sites and overall survival to improve risk stratification and surgical decision-making. A retrospective, single-center cohort study was conducted at Unidade Local de Saúde São João, Porto, Portugal. A total of 30 patients with a primary diagnosis of sinonasal ITAC between 2014 and 2024 who underwent surgical resection were included. Survival outcomes were evaluated using Kaplan-Meier survival analysis, with a specific focus on tumor laterality, dural and subpial invasion, sphenoid and orbital invasion, and overall tumor burden. Additionally, the effects of clinical and treatment-related parameters were evaluated. A significantly poorer survival was found in tumors with subpial invasion at diagnosis (p < 0.001), whereas dural invasion showed a trend toward significance (p = 0.053). The influence of orbital and sphenoid invasion on survival was negligible. Left-sided tumors showed a worse prognosis compared to right-sided lesions (p = 0.003). Patients selected for purely endoscopic surgical approaches and gross total resection (GTR) were linked with better outcomes. Our results emphasize the need for a comprehensive preoperative evaluation of important anatomical invasion locations and the prognostic importance of subpial invasion and tumor laterality in ITAC. Preoperatively identifying high-risk features may refine surgical planning and treatment choices, optimizing survival outcomes in this aggressive malignancy.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →